Literature DB >> 2116376

Regulation of IgE and IgG4 synthesis in patients with hyper IgE syndrome.

A Ishizaka1, K Joh, R Shibata, Y Wagatsuma, M Nakanishi, K Tomizawa, K Kojima, E Kandil, Y Sakiyama, S Matsumoto.   

Abstract

In order to investigate the imbalance of IgG subclasses and its relationship to IgE level, 14 patients with hyper IgE syndrome (HIE syndrome) were examined for serum IgG subclasses and IgE levels and five of these patients were studied for in vitro IgE and IgG subclass production by peripheral blood lymphocytes (PBL) in response to interleukin-4 (IL-4)/interferon-gamma (IFN-gamma). Serum IgE levels were highly correlative with serum IgG4 levels (r = 0.75, P less than 0.005), but not with IgG1, IgG2 or IgG3 levels (r = 0.21, 0.43 and 0.41, respectively). In an in vitro study, recombinant IL-4 enhanced not only spontaneous IgE synthesis but also IgG4 synthesis in cultures of PBL from patients with HIE syndrome as well as in healthy donors (P less than 0.01), and the effect of recombinant IL-4 on both IgE and IgG4 synthesis was inhibited by low concentrations of recombinant IFN-gamma (P less than 0.01). The disturbed regulation of IgE and IgG4 seen in patients with hyper IgE syndrome may be caused mainly by the disturbed regulation of both cytokines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116376      PMCID: PMC1384175     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

1.  Alpha-interferon treatment of patient with hyper IgE syndrome.

Authors:  G Souillet; F Rousset; J E de Vries
Journal:  Lancet       Date:  1989-06-17       Impact factor: 79.321

2.  Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome.

Authors:  G Del Prete; A Tiri; E Maggi; M De Carli; D Macchia; P Parronchi; M E Rossi; M C Pietrogrande; M Ricci; S Romagnani
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

3.  IgE and IgG4 subclass in atopic families.

Authors:  C M Gwynn; J M Smith; G L Leon; D R Stanworth
Journal:  Clin Allergy       Date:  1979-03

4.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

5.  Effect of recombinant human interleukin 4 on spontaneous in vitro human IgE synthesis.

Authors:  X D Yang; A L De Weck; B M Stadler
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

6.  Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.

Authors:  F D Finkelman; I M Katona; J F Urban; C M Snapper; J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.

Authors:  G Pluschke; G Bordmann; M E Daoudaki; J D Lambris; M Achtman; M Neibert
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

8.  Role of IgG4 subclass in childhood allergy.

Authors:  C M Gwynn; J M Smith; G L Leon; D R Stanworth
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

9.  IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; J Y Bonnefoy; H Spits; T Yokota; N Arai; K Arai; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures.

Authors:  D A Lebman; R L Coffman
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

  10 in total
  6 in total

1.  Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population.

Authors:  R Paganelli; I Quinti; U Fagiolo; A Cossarizza; C Ortolani; E Guerra; P Sansoni; L P Pucillo; E Scala; E Cozzi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Immunoglobulin response to intrapulmonary immunization of asthmatics.

Authors:  M Schuyler; C R Lyons; B Masten; D Bice
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 3.  Does allergen immunotherapy alter the natural course of allergic disorders?

Authors:  X Yang
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Hyper-response of serum IgG1 to Staphylococcus aureus peptidoglycan in patients with hyper-IgE syndrome.

Authors:  A Ishizaka; K Kojima; Y Sakiyama; S Matsumoto; K Kuwajima; Y Wagatsuma; R Shibata; K Joh
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

5.  Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease.

Authors:  R Riganò; E Profumo; S Ioppolo; S Notargiacomo; E Ortona; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

6.  In vitro production of cytokines by peripheral blood mononuclear cells from hydatid patients.

Authors:  R Riganò; E Profumo; G Di Felice; E Ortona; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.